ICON ICON is a clinical research organization that provides consulting, outsourced development, and commercialization services. | Standard BioTools Standard BioTools (formerly known as Fluidigm) is a biotechnology company that develops microfluidic-based chips and instrumentation for biological research. | |
Founding Date | Founding Date 1990 | Founding Date 1999 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ Sydney, AU Markham, CA Shanghai, CN Paris, FR Paris, FR München, DE see more | |
Employees | Employees 41,250 | Employees 5393% increase |
Valuation ($) | Valuation ($) 19.2 b | Valuation ($) 649.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $8.3b (FY, 2024) | Revenue (est.) $85.3m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $42.8m (FY, 2025) |
Gross profit | Gross profit $8.3b (FY, 2024) | Gross profit $42.5m (FY, 2025) |
Net income | Net income $791.5m (FY, 2024) | Net income ($74.9m) (FY, 2025) |
Standard BioTools (formerly known as Fluidigm) is a biotechnology company that develops microfluidic-based chips and instrumentation for biological research.
View company